New Technologies Improving Mental Health Care

Therabot just passed the world’s first clinical trial for an AI therapy chatbot. Developed by Dartmouth over 5 years, it’s already delivering real, measurable results that could change the face of mental health care. But it wasn’t always this way. When Therabot was first created, its early versions were a disaster: - One chatbot expressed suicidal thoughts. - Another blamed everything on your parents by question five. But the team at Dartmouth didn’t give up — they spent 3 years and 100+ people crafting custom training data from scratch to get it right. And it paid off. The results of the clinical trial? 👉 A 51% reduction in depression symptoms among participants. 👉 People with moderate anxiety saw their symptoms drop to “mild” levels. 👉 Some no longer met diagnostic criteria for anxiety or depression. 👉 And most surprisingly: Participants rated their connection to Therabot as equal to a human therapist. So what matters now? It works. It’s scalable. It’s always available, unlike human therapists who book months out. But if you ask me — I don’t believe it will replace human therapy anytime soon. However, with 70% of people around the world having no access to mental health care, Therabot might be their first real shot at getting the help they need. So the future of therapy won’t be 100% AI. But it could be AI-assisted, AI-augmented, and most importantly, AI-accessible. Because mental health care isn’t broken — it’s just undersupplied. And Therabot might not fix that overnight. But it’s the most science-backed step forward we’ve seen in years. So I’m hopeful. What’s your take on AI therapists? Could they be the solution for those who currently don’t have access to mental health care? #entrepreneurship #healthtech #AI #innovation

AI can quietly fix the gaps your clinicians see every day. Mental health waiting lists stretch for months. Women's health concerns get dismissed or overlooked. The system struggles to meet demand. This is where AI-driven platforms step in. Mood tracking tools monitor patterns that might take weeks to surface in traditional therapy sessions. Crisis intervention systems provide immediate support when human resources are stretched thin. Gender-specific health monitoring catches early warning signs that often slip through routine appointments. These platforms offer something your current infrastructure might struggle to provide: accessibility. A woman experiencing postpartum anxiety at 2am gets real-time support. A patient in a rural area tracks symptoms that inform their next specialist visit. Someone hesitant about traditional therapy finds a low-barrier entry point to mental health care. The technology handles what it does best: continuous monitoring, pattern recognition, data collection. Your clinicians handle what they do best: personalized care, complex decision-making, human connection. I spoke with a healthcare administrator last week. She was skeptical about AI in these sensitive areas. After exploring the applications, she realized something important. AI tools free up her clinical team to focus on the patients who need them most. The platforms handle routine monitoring and early intervention. Her specialists tackle the complex cases requiring human expertise. This approach reaches underserved populations who face the biggest barriers to care. It delivers tailored solutions at scale. It turns healthcare from reactive to proactive. The question becomes: how can you integrate these tools to amplify your existing care delivery?

AI isn't replacing therapists. But it might be the bridge to care that millions desperately need. New research reveals ChatGPT delivers high-quality psychoeducation when professional help isn't available. (Read more https://lnkd.in/e3e4ncDg) This matters because: ↳ 1 in 5 Americans struggle with mental illness yearly ↳ Mental health provider shortages are widespread ↳ Millions receive no care at all Psychoeducation is teaching people about  mental health conditions and coping strategies. It's a cornerstone of effective treatment. The new study tested ChatGPT across 7 critical areas: ↳ Depression and anxiety ↳ General health concerns ↳ Substance abuse issues ↳ Religious/spiritual matters ↳ Lifestyle and routine habits ↳ Interpersonal challenges The results? Remarkable. ChatGPT scored nearly perfect on: ↳ Accuracy (evidence-based responses) ↳ Clarity (plain, accessible language) ↳ Relevance (addressing specific needs) ↳ Empathy (supportive, understanding tone) ↳ Ethics (referring to professionals when needed) This isn't about replacing human care. It's about the millions who get no care at all. The greatest risk in mental health isn't trying new approaches. It's maintaining a status quo where most people suffering get nothing. The stakes couldn't be higher: ↳ ChatGPT isn't a therapist replacement ↳ It can't consider your medical history ↳ It won't address cultural nuances without context ↳ Privacy concerns remain significant But for someone with no access to care? Evidence-based psychoeducation is infinitely better than suffering alone. Mental health care isn't binary. It's a spectrum from no care to optimal care. AI might just help us fill the gap between silence and support. ==================== ⁉️ How could AI tools change access to mental health support? ♻️ Share if you believe everyone deserves mental health resources. 👉 Follow me (Eric Arzubi, MD) for more like this. ❤️ May is Mental Health Awareness Month.

Another clear shift we’re seeing across the nearly 500 mental health companies we’re tracking at Bezyl®: A move toward more objective and precise data. For decades, mental health has relied heavily on subjective reporting: How do you feel? How have you been this week? These questions are still important. But they don’t tell the full story. We’re now seeing a growing number of solutions beginning to incorporate: ·     Biometric signals (heart rate, sleep, nervous system activity) ·     Passive behavioral data (patterns over time, not just moments in time) ·     Real-world inputs that provide more continuous insight This isn’t about replacing human experience. It’s about adding another layer of understanding. Because mental health is dynamic, and what we capture in a single moment doesn’t always reflect what’s actually happening over time. We’re seeing this take shape in different ways across the ecosystem: Eye Minders → The eyes are a powerful interface to the brain, reflecting both mental effort and emotional state. Eye Minders is studying diagnostic approaches that could enable more precise detection of mood, stress, depression, and even PTSD. Appscent Medical → Developed SCENTIFIC, A Class II medical device designed to support relaxation through contactless, scent-based biofeedback. Using radar-based respiratory sensing and olfactory cues, the system monitors breathing patterns and gently guides awareness during rest and sleep. Reflect Innovation → Developed an orb that helps individuals track and regulate stress in real time. By simply holding it, users can see their physiological state shift as the orb responds from stress to calm. Equanimity AI → Developed Beacon, an operating system currently used to monitor pain between patient visits, with plans to extend this personalized diagnostic approach into mental wellness and broader therapeutic applications. Different approaches. Same underlying shift. This shift has the potential to: ·     Improve how we understand mental states ·     Enable more personalized support ·     And help identify changes earlier and more accurately But it also raises important questions: ·     How do we interpret these data responsibly? ·     How do we ensure privacy and trust? ·     And how do we integrate it into care in a meaningful way? This is still an emerging area, but it’s one that will play a critical role in how mental health evolves. We’ll continue to highlight more companies building in this space as we move forward. Sign up for early access to our global mental health map coming soon! https://bezyl.com/contact/ Daphna Palti-Wasserman Erez Levanon Noga Sapir Yosi A.

𝐌𝐞𝐧𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 (𝐃𝐓𝐱) 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞 The current landscape of digital therapeutics (DTx) for mental health illustrates a significant transformation in how mental health conditions are treated, with a focus on innovative, accessible, and personalized care. Personalization and Customization A major trend across DTx products is the emphasis on personalized treatments tailored to individual needs. Advanced technologies such AI, VR, and real-time biometric data are employed to adapt therapies based on personal health patterns and responses. Increased Accessibility and Convenience DTx products leverage mobile and web applications to make mental health care more accessible. This is crucial in reducing barriers to accessing therapy, such as stigma or geographical limitations. Companies like SilverCloud® and BeMe Health provide therapeutic interventions directly to users’ devices, allowing for private and convenient access to mental health care, which can be particularly appealing to those reluctant to engage in traditional therapy settings. Gamification and Engaging Content To enhance engagement and adherence, many DTx companies incorporate gamification and interactive elements into their therapies. This approach, utilized by companies like BFB Labs and Arcade Therapeutics, makes treatment more appealing, especially to younger demographics who might find game-based interventions more engaging than conventional therapies. Focus on Regulatory Compliance and Clinical Validation As the DTx field matures, companies are increasingly focusing on obtaining regulatory approvals and validating their solutions through clinical trials. This not only ensures the efficacy and safety of digital therapies but also helps in building trust among users and healthcare providers. Companies like Click Therapeutics, Inc. and Big Health are at the forefront, conducting rigorous studies to secure FDA approval for their products. Technological Innovations Innovation in technology is a hallmark of the DTx sector, with companies utilizing VR, AI, and other advanced technologies to create more immersive and effective therapeutic experiences. This is evident in the work of companies like XRHealth (formerly Amelia), which uses VR to simulate therapeutic scenarios that help patients manage conditions like anxiety and PTSD in a controlled environment. The DTx sector represents a progressive shift in mental health care, emphasizing patient-centered approaches that harness technological advancements to improve accessibility, personalize care, and enhance patient engagement. This dynamic field continues to evolve, promising to reshape mental health practices with innovative solutions that bridge the gap between technology and traditional care. #MentalHealth #DigitalTherapeutics #DTx #DigitalHealth

The paper in the comments - in collaboration with Luke E Stoeckel, PhD and Layla Esposito - discusses the emerging field of Prescription Digital Therapeutics (PDTs) and their role in mental and brain health treatment. PDTs are a subset of Software as Medical Device (SaMD) regulated by the FDA for treating patients. We explain how these FDA-regulated tools differ from traditional wellness applications and their potential to improve mental health outcomes. PDTs offer several advantages over traditional pharmacotherapy, including real-time intervention, personalization, and potentially fewer side effects. NIH supports research on Digital Health Technologies (DHTs) in mental and brain health. Key NIH funding programs and the current PDT landscape are discussed, particularly focusing on NICHD, NIMH, and NIA efforts. We highlight several challenges and provide potential solutions in PDT development, including: ·      Addressing usability and accessibility barriers ·      Involving target communities in the development process ·      Developing technical and medical standards ·      Ensuring safety, efficacy, and widespread adoption ·      How can PDTs be integrated into daily mental health routines ·      What are the unique therapeutic approaches employed by PDTs ·      How do PDTs address usability and accessibility barriers ·      What are the opportunities and challenges in the PDT landscape for brain health ·      How does the NIH support the development of digital therapeutics The paper suggests several strategies to improve PDT safety and effectiveness: ·      Developing technical and medical standards ·      Enhancing usability and accessibility ·      Involving target communities in development ·      Conducting rigorous clinical trials ·      Gathering real-world evidence ·      Addressing ethical and privacy concerns ·      Improving integration with healthcare systems ·      Enhancing personalization and adaptability #DigitalHealth #MentalHealth #PrescriptionDigitalTherapeutics #NIH #InnovationInHealthcare #SaMD

“CBT-based app” is one of the most overused and least useful phrases in digital mental health. As a psychiatry doctor, I see the unmet need every day: long waits for psychiatric care, long waits for talking therapies, and people left trying to manage distress without timely support. I do believe digital health can improve access. But access to an app is not the same as access to therapy. For digital mental health to be clinically meaningful, we need to know what is actually being delivered. Right now, very different interventions are being bundled under the same neat label. One “CBT-based” app might offer mood tracking and psychoeducation. Another might include behavioural activation, exposure therapy, cognitive restructuring, problem-solving, goal setting or habit formation. Same label. Completely different therapeutic ingredients. That is why this new meta-analysis of 169 RCTs in npj Digital Medicine is so important. Instead of treating mental health apps as one broad category, it looks at the specific components that may be driving outcomes. The “active ingredients” might include: • Behavioural activation: scheduling meaningful activities to improve mood • Cognitive restructuring: identifying and challenging unhelpful thoughts • Exposure therapy: gradually approaching feared situations or triggers • Problem-solving therapy: breaking problems into manageable steps • Goal setting and habit formation: supporting structured behaviour change • Psychoeducation and symptom monitoring: learning about symptoms and tracking patterns This is the level of precision the field urgently needs. Not “Is it CBT-based?” But: What is the therapeutic mechanism? For whom? In what context? With what level of human support? And does it work in the real world, where people are busy, distressed, distracted, unsupported, and far more complex than a trial population? The future of digital mental health should not be an endless marketplace of more apps. It should be better evidence, clearer mechanisms, stronger engagement, and measurable clinical benefit. Dr Faith Ndebele | Liz Ashall-Payne | Kate Newhouse, CMgr CCMI | Jo Aggarwal #digitalmentalhealth #psychiatry #mentalhealthinnovation #healthtech

Mental Health Can’t Be an Afterthought in Oncology Anymore We’ve sequenced tumors. We’ve mapped biomarkers. We’ve built AI systems that can predict treatment response from a tissue slide. Precision oncology has transformed cancer care. And yet. 1 in 3 cancer patients has a diagnosable mental health condition. 60% never receive a referral for screening. 2 in 5 who ask for support don’t get it. We’ve applied extraordinary rigor to the molecular signature of disease. We haven’t come close to applying that same rigor to the psychological experience of the people living with it. That’s starting to change. I’m a decent oncologist. I can talk your ear off about minimal residual disease testing and cytokine release syndrome protocols. But data-driven mental health care? I’m learning alongside everyone else. Medical school didn’t teach me measurement-based psychiatric care. I can order an NGS panel in my sleep, but ask me to interpret a longitudinal PHQ-9 trajectory and I’m reaching for help. This isn’t a criticism. It’s an opportunity. We need our mental health professional colleagues to educate us. What does precision mental health care actually look like? How do we build it into cancer care the way we’ve built in tumor boards and molecular testing? The Emerging Landscape Tech-Enabled Collaborative Care. The Collaborative Care Model—backed by over 90 randomized trials—is getting a digital upgrade. Behavioral health care managers and psycho-oncologists are integrating directly into oncology practices, tracking symptoms in real time. Early adopters are seeing 58% improvements in depression scores within three months. Depression remission in 86 days versus 614 days in usual care. That’s nearly two years of suffering addressed through better process engineering. Early Warning Systems. AI tools are scanning clinical notes and portal messages for linguistic markers of distress—identifying patients who need support before crisis hits. We’re shifting from reactive callbacks to proactive outreach. Virtual Care Without Borders. Geography no longer dictates access. Digital therapeutics deliver evidence-based cognitive behavioral therapy directly to a patient’s phone. These aren’t meditation apps—they’re prescription-grade interventions calibrated to the cancer journey. 24/7 Support That Works. AI-enabled platforms offer round-the-clock symptom monitoring with escalation to oncology-trained clinicians. A patient waking up terrified at 2 AM can reach out and get a response. The common thread? Technology isn’t replacing human empathy. It’s scaling it. I’m organizing a Virtual Summit on the Future of Oncology Mental Health Care—bringing together national thought leaders on where we are and where we’re headed. I’m looking for collaborators. If you’re a digital health innovator, or clinician doing this work—I want to learn from you. If you represent an organization aligned with this mission and interested in sponsoring or partnering—let’s talk.

I’ve spent the last few years building products that use AI to solve real challenges in the world. Studies like this one are both encouraging and energizing. A new randomized controlled trial from Dartmouth College evaluated Therabot, a GenAI-powered chatbot. The study found significant reductions in symptoms of depression, anxiety, and eating disorders relative to a waitlist control. This is a meaningful step forward. It shows that AI can do more than increase access. It can improve the quality of care. But results like these require more than technology. They depend on thoughtful design, clinical depth, rigorous safety and a deep understanding of the people we are building for. That is the future I am focused on. One where AI enhances care without replacing it, and where trust is built into every layer of the experience. There’s a lot to be excited about here. What do you think is most important as we move from promising studies to real-world adoption? Full study here: https://lnkd.in/eSrw7tS5

Virtual Mental Health Assistants (VMHAs) are changing the game in mental health care. My colleagues at HoloMD are vanguards. Let me explain. For many, accessing mental health support has always been a challenge—scheduling appointments, finding the right therapist, or simply overcoming the stigma. But here’s how VMHAs are making a difference: → 24/7 Availability Unlike traditional therapy, VMHAs are available whenever you need them. Whether it's the middle of the night or early morning, support is just a message away. → Personalized Support These AI-driven assistants learn from each interaction, adapting to provide coping strategies and resources tailored to your unique needs. → Reducing Stigma Anonymity can be powerful. VMHAs offer a judgment-free zone, encouraging people to seek help without fear of judgment. → Consistent Care VMHAs follow established protocols, ensuring users receive reliable, standardized support every time. → Complementing Traditional Therapy While they’re not a replacement for human therapists, VMHAs provide ongoing support between sessions, help track progress, and offer insights that can be shared with therapists. In short, virtual mental health assistants are bridging gaps in mental health care, making it more accessible, personalized, and stigma-free. As technology advances, these tools will play an even more significant role in supporting mental wellness. Could this be the future of mental health care?